Ocular Therapeutix (FRA:0OT) Accounts Payable & Accrued Expense : €20.69 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Ocular Therapeutix Accounts Payable & Accrued Expense?

Ocular Therapeutix's quarterly accounts payable & accrued expense declined from Sep. 2023 (€30.80 Mil) to Dec. 2023 (€30.31 Mil) and declined from Dec. 2023 (€30.31 Mil) to Mar. 2024 (€20.69 Mil).

Ocular Therapeutix's annual accounts payable & accrued expense increased from Dec. 2021 (€21.87 Mil) to Dec. 2022 (€27.58 Mil) and increased from Dec. 2022 (€27.58 Mil) to Dec. 2023 (€30.31 Mil).

Ocular Therapeutix Accounts Payable & Accrued Expense Historical Data

The historical data trend for Ocular Therapeutix's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocular Therapeutix Accounts Payable & Accrued Expense Chart

Ocular Therapeutix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

9.81

13.99

21.87

27.58

30.31

Ocular Therapeutix Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															25.62	26.00	30.80	30.31	20.69

Ocular Therapeutix Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Ocular Therapeutix (FRA:0OT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (FRA:0OT) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

OCUL:USA 0OT:Germany

Address

24 Crosby Drive, Bedford, MA, USA, 01730

Website

https://www.ocutx.com

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ocular Therapeutix (FRA:0OT) Headlines

No Headlines